secwatch.observer — SEC 8-K summary
======================================

Issuer:     Organogenesis Holdings Inc. (ORGO)
CIK:        0001661181
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001193125-24-165670
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve 15.9M share increase to 2018 Equity Incentive Plan
-----------------------------------------------------------------------

- All 11 director nominees elected; votes ranged from 41.5M to 68.4M for, with broker non-votes of 39.3M.
- Advisory vote on executive compensation passed with 63.8M for, 5.9M against.
- Amendment to 2018 Equity Incentive Plan adding 15,900,000 shares approved (52.0M for, 17.7M against).
- Ratification of RSM US LLP as independent auditor for FY2024 passed (106.4M for, 2.6M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661181/000119312524165670/0001193125-24-165670-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661181/000119312524165670/d826313d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-165670

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer